March 6, 2019
Otsuka Pharmaceutical said on March 5 that it has rolled out Selincro (nalmefene), the first therapeutic drug treatment to reduce alcohol consumption in alcohol-dependent patients in Japan. Codeveloped by Otsuka and its Danish partner Lundbeck A/S, Selincro is an opioid...read more